Impact and Cost-Effectiveness of Hypothetical Strategies to Enhance Retention in Care within HIV Treatment Programs in East Africa

Value in Health

Volumn 18, Issue 8, 2015, Pages 946-955

  Kessler, Jason ^a   Nucifora, Kimberly ^a   Li, Lingfeng ^a   Uhler, Lauren ^a   Braithwaite, Scott ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Africa; cost effectiveness analysis; health care utilization; HIV AIDS

Indexed keywords

ADULT; AFRICA; ART THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; COST EFFECTIVENESS ANALYSIS; DISEASE COURSE; FOLLOW UP; HEALTH CARE PLANNING; HEALTH CARE UTILIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFE EXPECTANCY; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RISK REDUCTION; SENSITIVITY ANALYSIS; COMPUTER SIMULATION; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; HIV INFECTIONS; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; MORTALITY; PATIENT COMPLIANCE; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

ANTIRETROVIRUS AGENT;

ADULT; AFRICA, EASTERN; ANTI-RETROVIRAL AGENTS; COMPUTER SIMULATION; COST-BENEFIT ANALYSIS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MODELS, ECONOMETRIC; PATIENT COMPLIANCE; RISK REDUCTION BEHAVIOR;

EID: 84951573734     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2015.09.2940     Document Type: Article

References (58)

1. S. Rosen, C.J. Gill, and M.P. Fox Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review PLoS Med 4 2007 e298
2. S. Rosen, and M.P. Fox Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review PLoS Med 8 2011 e1001056
3. M.P. Fox, and S. Rosen Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review Trop Med Int Health 15 Suppl. 1 2010 1 15
4. R. Jurgens, J. Cohen, D. Tarantola, and et al. Universal voluntary HIV testing and immediate antiretroviral therapy Lancet 373 2009 1080 1081
5. P.S. Sow, E. Bissagnene, C. Kityo, and et al. Implementation of an antiretroviral access program for HIV-1 infected individuals in resource-limited settings: clinical results from 4 African countries J Acquir Immune Defic Syndr 44 2007 262 267
6. L.C. Ivers, and K.K.D. Doucette Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature Clin Infect Dis 41 2005 217 224
7. E.H. Geng, N. Emenyonu, M.B. Bwana, and et al. Sampling-based approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in Africa JAMA 300 2008 506 507
8. E.H. Geng, D.V. Glidden, M.B. Bwana, and et al. Retention in care and connection to care among HIV-infected patients on antiretroviral therapy in Africa: estimation via a sampling-based approach PLoS One 6 2011 e21797
9. M.W. Brinkhof, M. Pujades-Rodriguez, and M. Egger Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis PLoS One 4 2009 e5790
10. R. Weigel, M. Hochgesang, M.W. Brinkhof, and et al. Outcomes and associated risk factors of patients traced after being lost to follow-up from antiretroviral treatment in Lilongwe, Malawi BMC Infect Dis 11 2011 31
11. J.H. McMahon, J.H. Elliott, S.Y. Hong, and et al. Effects of physical tracing on estimates of loss to follow-up, mortality and retention in low and middle income country antiretroviral therapy programs: a systematic review PLoS One 8 2013 e56047
12. H. Tweya, D. Gareta, F. Chagwera, and et al. Early active follow-up of patients on antiretroviral therapy (ART) who are lost to follow-up: the "Back-to-Care" project in Lilongwe, Malawi Trop Med Int Health 15 Suppl. 1 2010 82 89
13. D.W. Krebs, B.H. Chi, Y. Mulenga, and et al. Community-based follow-up for late patients enrolled in a district-wide programme for antiretroviral therapy in Lusaka, Zambia AIDS Care 20 2008 311 317
14. M.R. Lamb, W.M. El-Sadr, E. Geng, and D. Nash Association of adherence support and outreach services with total attrition, loss to follow-up, and death among ART patients in sub-Saharan Africa PLoS One 7 2012 e38443
15. N. Emenyonu, W. Muyindike, J. Habyarimana, and et al. Cash transfers to cover clinic transportation costs improve adherence and retention in care in a HIV treatment program in Rural Uganda. Presented at: 17th Conference on Retroviruses and Opportunistic Infections 2010 San Francisco CA
16. P.K. Kohler, M.H. Chung, C.J. McGrath, and et al. Implementation of free cotrimoxazole prophylaxis improves clinic retention among antiretroviral therapy-ineligible clients in Kenya AIDS 25 2011 1657 1661
17. P. Braitstein, A. Siika, J. Hogan, and et al. A clinician-nurse model to reduce early mortality and increase clinic retention among high-risk HIV-infected patients initiating combination antiretroviral treatment J Int AIDS Soc 15 2012 7
18. M.F. Franke, F. Kaigamba, A.R. Socci, and et al. Improved retention associated with community-based accompaniment for antiretroviral therapy delivery in rural Rwanda Clin Infect Dis 56 2013 1319 1326
19. R.S. Braithwaite, K.A. Nucifora, C.T. Yiannoutsos, and et al. Alternative antiretroviral monitoring strategies for HIV-infected patients in east Africa: opportunities to save more lives? J Int AIDS Soc 14 2011 38
20. R.S. Braithwaite, A.C. Justice, C-CH Chang, and et al. Estimating the proportion of patients infected with HIV who will die of comorbid diseases Am J Med 118 2005 890 898
21. R.S. Braithwaite, M.S. Roberts, C.C.H. Chang, and et al. Influence of alternative thresholds for initiating HIV treatment on quality-adjusted life expectancy: a decision model Ann Intern Med 148 2008 178 185
22. World Health Organization Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach 2010 World Health Organization Geneva
23. World Health Organization Global Update on HIV Treatment 2013: Results, Impact and Opportunities 2013 World Health Organization Geneva Available from: http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2013/20130630-treatment-report-en.pdf
24. K. Kranzer, S.D. Lawn, L.F. Johnson, and et al. Community viral load and CD4 count distribution among people living with HIV in a South African Township: implications for treatment as prevention J Acquir Immune Defic Syndr 63 2013 498 505
25. L.S. Wilkinson, J. Skordis-Worrall, O. Ajose, and N. Ford Self-transfer and mortality amongst adults lost to follow-up in ART programmes in low- and middle-income countries: systematic review and meta-analysis Trop Med Int Health 20 2015 365 379
26. G. Fatti, G. Meintjes, J. Shea, and et al. Improved survival and antiretroviral treatment outcomes in adults receiving community-based adherence support: 5-year results from a multicentre cohort study in South Africa J Acquir Immune Defic Syndr 61 2012 e50 e58
27. K.E. Torpey, M.E. Kabaso, L.N. Mutale, and et al. Adherence support workers: a way to address human resource constraints in antiretroviral treatment programs in the public health setting in Zambia PLoS One 3 2008 e2204
28. S.T. Alamo, G.J. Wagner, P. Sunday, and et al. Electronic medical records and same day patient tracing improves clinic efficiency and adherence to appointments in a community based HIV/AIDS care program in Uganda AIDS Behav 16 2012 368 374
29. J. Estill, H. Tweya, M. Egger, and et al. Tracing of patients lost to follow-up and HIV transmission: mathematical modeling study based on 2 large ART programs in Malawi J Acquir Immune Defic Syndr 65 2014 e179 e186
30. B. Mukhuna, M. McGuire, K. Taremba, and et al. Outcomes of patient active tracing by lay community workers in a decentralized HIV care program of rural Malawi. Presented at: 5th IAS Conference on HIV Pathogenesis Treatment, and Prevention, Cape Town, South Africa 2009
31. H. Tweya, C. Feldacker, J. Estill, and et al. Are they really lost? "True" status and reasons for treatment discontinuation among HIV infected patients on antiretroviral therapy considered lost to follow up in Urban Malawi PLoS One 8 2013 e75761
32. Bank TW. Gross domestic product per capita. Available from: http://data.worldbank.org/indicator/NY.GDP.PCAP.CD. [Accessed March 1, 2015]
33. T.T. Edejer, T. Adam, R. Hutubessy, and et al. Making Choices in Health: WHO Guide to Cost-Effectiveness Analysis 2003 World Health Organization Geneva
34. Frontieres MS. Providing antiretroviral therapy for mobile populations: lessons learned from a cross border ARV programme in Musina, South Africa, 2012. Available from: http://www.msfaccess.org/sites/default/files/MSF-assets/HIV-AIDS/Docs/AIDS-report-ARTformobilepops-ENG-2012.pdf. [Accessed March 1, 2015]
35. E. Losina, H. Toure, L.M. Uhler, and et al. Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Cote d'Ivoire appraisal PLoS Med 6 2009 e1000173
36. E.H. Geng, D.V. Glidden, N. Emenyonu, and et al. Tracking a sample of patients lost to follow-up has a major impact on understanding determinants of survival in HIV-infected patients on antiretroviral therapy in Africa Trop Med Int Health 15 Suppl. 1 2010 63 69
37. E.H. Geng, N. Musinguzi, N. Emenyonu, and et al. Understanding reasons for and outcomes of patients lost to follow-up in antiretroviral therapy programs in Africa through a sampling-based approach J Acquir Immune Defic Syndr 53 2010 405 411
38. E.H. Geng, D. Nash, A. Kambugu, and et al. Retention in care among HIV-infected patients in resource-limited settings: emerging insights and new directions Curr HIV/AIDS Rep 7 2010 234 244
39. C.M. Miller, M. Ketlhapile, H. Rybasack-Smith, and S. Rosen Why are antiretroviral treatment patients lost to follow-up? A qualitative study from South Africa Trop Med Int Health 15 Suppl. 1 2010 48 54
40. R. Weigel, M. Hochgesang, M.W. Brinkhof, and et al. Outcomes and associated risk factors of patients traced after being lost to follow-up from antiretroviral treatment in Lilongwe, Malawi BMC Infect Dis 11 2011 31
41. G.P. Bisson, R. Gross, R.e.V. Lo, and et al. Out-of-pocket costs of HAART limit HIV treatment responses in Botswana's private sector AIDS 20 2006 1333 1336
42. A.D. Harries, R. Zachariah, S.D. Lawn, and S. Rosen Strategies to improve patient retention on antiretroviral therapy in sub-Saharan Africa Trop Med Int Health 15 Suppl. 1 2010 70 75
43. R. Zachariah, M. Massaquoi, L. Kocholla, and et al. Payment for antiretroviral drugs is associated with a higher rate of patients lost to follow up than those offered free-of-charge therapy in Nairobi, Kenya Trans R Soc Trop Med Hyg 102 2008 288 293
44. T.C. Quinn, N. Sewankambo, M.B. Serwadda, and et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1 N Engl J Med 342 2000 921 929
45. M.S. Cohen, Y.Q. Chen, M. McCauley, and et al. Prevention of HIV-1 infection with early antiretroviral therapy N Engl J Med 365 2011 493 505
46. B.A. Larson, A. Brennan, L. McNamara, and et al. Early loss to follow up after enrolment in pre-ART care at a large public clinic in Johannesburg, South Africa Trop Med Int Health 15 Suppl. 1 2010 43 47
47. M.R. Lamb, R. Fayorsey, H. Nuwagaba-Biribonwoha, and et al. High attrition before and after ART initiation among youth (15-24 years of age) enrolled in HIV care AIDS 28 2014 559 568
48. D. Govindasamy, J. Meghij, E. Kebede Negussi, and et al. Interventions to improve or facilitate linkage to or retention in pre-ART (HIV) care and initiation of ART in low- and middle-income settings - a systematic review J Int AIDS Soc 17 2014 19032
49. E.H. Geng, M.B. Bwana, W. Muyindike, and et al. Failure to initiate antiretroviral therapy, loss to follow-up and mortality among HIV-infected patients during the pre-ART period in Uganda J Acquir Immune Defic Syndr 63 2013 e64 e71
50. E.J. Mills, A. Funk, S. Kanters, and et al. Long-term health care interruptions among HIV-positive patients in Uganda J Acquir Immune Defic Syndr 63 2013 e23 e27
51. J. Luebbert, H. Tweya, S. Phiri, and et al. Virological failure and drug resistance in patients on antiretroviral therapy after treatment interruption in Lilongwe, Malawi Clin Infect Dis 55 2012 441 448
52. M. Mann, L. Diero, E. Kemboi, and et al. Antiretroviral treatment interruptions induced by the Kenyan postelection crisis are associated with virological failure J Acquir Immune Defic Syndr 64 2013 220 224
53. N.P. Pai, J.P. Tulsky, J. Lawrence, and et al. Structured treatment interruptions (STI) in chronic suppressed HIV infection in adults Cochrane Database Syst Rev 2005 CD005482. October, 19(4)
54. L.N. Ncaca, K. Kranzer, and C. Orrell Treatment interruption and variation in tablet taking behaviour result in viral failure: a case-control study from Cape Town, South Africa PLoS One 6 2011 e23088
55. B. Rachlis, D. Ochieng, E. Geng, and et al. Evaluating outcomes of patients lost to follow-up in a large comprehensive care treatment program in western Kenya J Acquir Immune Defic Syndr (published online ahead of print January 16, 2015 10.1097/QAI.0000000000000492
56. Ochieng D, Braitstein P, Ochieng V, et al. Patient track ing and retention in a resource-constrained setting: the AMPATH experience in western Kenya. Presented at: 4th IAS Conference on HIV Pathogenesis, Treatment, and Prevention: Abstract no. CDB493, Sydney, Australia
57. 2013 Report on costs of treatment in the President's Emergency Plan for AIDS Relief (PEPFAR). Available from: http://www.pepfar.gov/documents/organization/212059.pdf. [Accessed March 20, 2015]
58. L. Guinness, G. Arthur, S.M. Bhatt, and et al. Costs of hospital care for HIV-positive and HIV-negative patients at Kenyatta National Hospital, Nairobi, Kenya AIDS 16 2002 901 908